Cizzle Biotechnology Holdings PLC, the UK based diagnostics developer, is pleased to announce that it has entered into an agreement with the Behnke Group,...
Nonagen Bioscience, a cancer diagnostics company, announced CE marking for its Oncuria immunoassay for bladder cancer.
Oncuria is the first-of-its-kind multiplex urine test for the...
Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driving digitalization and innovation across the pharmaceutical value...
Nordic Bioscience, a growing biomarker company, announced the strengthening of its ongoing collaboration with Roche Diagnostics for the development of proprietary biomarkers involved in...
Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of...
